Login to Your Account



Combined Firm Adds £15M

'One-Stop Shop' RNAi Delivery Firm; Silence, Intradigm Merge

By Jennifer Boggs


Thursday, December 17, 2009
UK-listed Silence Therapeutics plc and privately held Intradigm Corp. agreed to a merger deal that could give the combined firm a competitive edge in the RNAi landscape currently dominated by firms such as Alnylam Pharmaceuticals Inc. and Sirna Therapeutics Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription